Overview

Golidocitinib Combined With GemOx in RR PTCL

Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of golidocitinib in combination with the GemOx regimen in r/r PTCL
Phase:
PHASE2
Details
Lead Sponsor:
Ruijin Hospital